Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform 2025-08-13 15:36
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration 2025-08-13 09:44
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model 2025-08-13 07:00
Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs 2025-08-12 22:00
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million 2025-08-12 09:36
Intas & Accord signs Agreement to acquire Prothya Biosolutions 2025-08-11 21:41
AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development 2025-08-11 21:30
AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs 2025-08-11 20:00
Everest Medicines to Announce 2025 Interim Results on August 29, 2025 2025-08-11 17:11
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy 2025-08-11 10:52
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment 2025-08-11 09:00
Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain 2025-08-11 09:00
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System 2025-08-09 09:30
GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology 2025-08-08 20:30
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA 2025-08-08 17:50
Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests 2025-08-08 17:45
WuXi XDC Included in MSCI China All Share Index 2025-08-08 17:32
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform 2025-08-08 09:30
1 25 26 27 28 29 525